Literature DB >> 32157430

"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.

Luca Giovanella1,2,3, Frederik A Verburg4,5, Petra Petranović Ovčariček4,6, Ioannis Iakovou4,7, Jasna Mihailovic4,8,9, Alexis Vrachimis4,10, Slimane Zerdoud4,11, Martha Hoffmann4,12, Markus Luster4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32157430     DOI： 10.1007/s00259-020-04748-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

1.  Thyroid function and the risk of dementia: The Rotterdam Study.

Authors:  Layal Chaker; Frank J Wolters; Daniel Bos; Tim I M Korevaar; Albert Hofman; Aad van der Lugt; Peter J Koudstaal; Oscar H Franco; Abbas Dehghan; Meike W Vernooij; Robin P Peeters; M Arfan Ikram
Journal:  Neurology       Date:  2016-09-16       Impact factor: 9.910

2.  Methimazole and risk of acute pancreatitis.

Authors:  Thomas H Brix; Lars C Lund; Daniel P Henriksen; Lars Folkestad; Steen J Bonnema; Jesper Hallas; Laszlo Hegedüs
Journal:  Lancet Diabetes Endocrinol       Date:  2020-02-05       Impact factor: 32.069

3.  Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.

Authors:  Frederik A Verburg; Martha Hoffmann; Ioannis Iakovou; Mark W Konijnenberg; Jasna Mihailovic; Pablo Minguez Gabina; Petra Petranović Ovčariček; Cristoph Reiners; Alexis Vrachimis; Slimane Zerdoud; Luca Giovanella; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03       Impact factor: 9.236

4.  Association of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?

Authors:  Elif Hindié; Kenneth B Ain; Slimane Zerdoud; Anca M Avram
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  There Is No Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism.

Authors:  Bennett S Greenspan; Jeffry A Siegel; Aamna Hassan; Edward B Silberstein
Journal:  J Nucl Med       Date:  2019-10-04       Impact factor: 10.057

6.  Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH.

Authors:  Mads Lillevang-Johansen; Bo Abrahamsen; Henrik Løvendahl Jørgensen; Thomas Heiberg Brix; Laszlo Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

7.  Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular Risk.

Authors:  Mads Lillevang-Johansen; Bo Abrahamsen; Henrik Løvendahl Jørgensen; Thomas Heiberg Brix; Laszlo Hegedüs
Journal:  Thyroid       Date:  2019-02-13       Impact factor: 6.568

8.  Joint statement from the Society for Endocrinology and the British Thyroid Association regarding 'Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism'.

Authors:  Peter N Taylor; Onyebuchi E Okosieme; Krishna Chatterjee; Kristien Boelaert
Journal:  Clin Endocrinol (Oxf)       Date:  2019-12-13       Impact factor: 3.478

9.  Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.

Authors:  Naomi Gronich; Idit Lavi; Gad Rennert; Walid Saliba
Journal:  Thyroid       Date:  2020-01-23       Impact factor: 6.568

10.  Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.

Authors:  Cari M Kitahara; Amy Berrington de Gonzalez; Andre Bouville; Aaron B Brill; Michele M Doody; Dunstana R Melo; Steven L Simon; Julie A Sosa; Mark Tulchinsky; Daphnée Villoing; Dale L Preston
Journal:  JAMA Intern Med       Date:  2019-08-01       Impact factor: 21.873
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.